annual current liabilities:
$87.78M-$21.01M(-19.31%)Summary
- As of today (June 29, 2025), CRSP annual total current liabilities is $87.78 million, with the most recent change of -$21.01 million (-19.31%) on December 31, 2024.
- During the last 3 years, CRSP annual current liabilities has fallen by -$32.10 million (-26.78%).
- CRSP annual current liabilities is now -27.52% below its all-time high of $121.11 million, reached on December 31, 2022.
Performance
CRSP Current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly current liabilities:
$119.45M+$31.66M(+36.07%)Summary
- As of today (June 29, 2025), CRSP quarterly total current liabilities is $119.45 million, with the most recent change of +$31.66 million (+36.07%) on March 31, 2025.
- Over the past year, CRSP quarterly current liabilities has increased by +$457.00 thousand (+0.38%).
- CRSP quarterly current liabilities is now -20.83% below its all-time high of $150.87 million, reached on September 30, 2022.
Performance
CRSP quarterly current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Current liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
CRSP Current liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -19.3% | +0.4% |
| 3 y3 years | -26.8% | +5.1% |
| 5 y5 years | +53.7% | +116.8% |
CRSP Current liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -27.5% | at low | -20.8% | +36.1% |
| 5 y | 5-year | -27.5% | +53.7% | -20.8% | +116.8% |
| alltime | all time | -27.5% | +3990.5% | -20.8% | +1076.2% |
CRSP Current liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $119.45M(+36.1%) |
| Dec 2024 | $87.78M(-19.3%) | $87.78M(-2.3%) |
| Sep 2024 | - | $89.81M(-29.7%) |
| Jun 2024 | - | $127.82M(+7.4%) |
| Mar 2024 | - | $118.99M(+9.4%) |
| Dec 2023 | $108.79M(-10.2%) | $108.79M(-2.2%) |
| Sep 2023 | - | $111.23M(-16.3%) |
| Jun 2023 | - | $132.84M(-9.5%) |
| Mar 2023 | - | $146.79M(+21.2%) |
| Dec 2022 | $121.11M(+1.0%) | $121.11M(-19.7%) |
| Sep 2022 | - | $150.87M(+25.8%) |
| Jun 2022 | - | $119.96M(+5.5%) |
| Mar 2022 | - | $113.70M(-5.2%) |
| Dec 2021 | $119.88M(+27.2%) | $119.88M(+24.6%) |
| Sep 2021 | - | $96.21M(-3.7%) |
| Jun 2021 | - | $99.92M(+20.3%) |
| Mar 2021 | - | $83.09M(-11.8%) |
| Dec 2020 | $94.26M | $94.26M(+12.0%) |
| Sep 2020 | - | $84.15M(+12.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2020 | - | $74.50M(+35.3%) |
| Mar 2020 | - | $55.09M(-3.5%) |
| Dec 2019 | $57.11M(+105.8%) | $57.11M(-28.4%) |
| Sep 2019 | - | $79.78M(+154.0%) |
| Jun 2019 | - | $31.41M(+10.6%) |
| Mar 2019 | - | $28.40M(+2.3%) |
| Dec 2018 | $27.75M(+91.2%) | $27.75M(-14.0%) |
| Sep 2018 | - | $32.28M(+74.7%) |
| Jun 2018 | - | $18.48M(+28.4%) |
| Mar 2018 | - | $14.39M(-0.8%) |
| Dec 2017 | $14.51M(-34.0%) | $14.51M(+19.8%) |
| Sep 2017 | - | $12.12M(-23.4%) |
| Jun 2017 | - | $15.81M(-6.5%) |
| Mar 2017 | - | $16.91M(-23.1%) |
| Dec 2016 | $22.00M(+116.6%) | $22.00M(-71.8%) |
| Sep 2016 | - | $78.10M(-3.1%) |
| Jun 2016 | - | $80.60M(+693.7%) |
| Dec 2015 | $10.15M(+373.2%) | $10.15M |
| Dec 2014 | $2.15M | - |
FAQ
- What is CRISPR Therapeutics AG annual total current liabilities?
- What is the all time high annual current liabilities for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG annual current liabilities year-on-year change?
- What is CRISPR Therapeutics AG quarterly total current liabilities?
- What is the all time high quarterly current liabilities for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG quarterly current liabilities year-on-year change?
What is CRISPR Therapeutics AG annual total current liabilities?
The current annual current liabilities of CRSP is $87.78M
What is the all time high annual current liabilities for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high annual total current liabilities is $121.11M
What is CRISPR Therapeutics AG annual current liabilities year-on-year change?
Over the past year, CRSP annual total current liabilities has changed by -$21.01M (-19.31%)
What is CRISPR Therapeutics AG quarterly total current liabilities?
The current quarterly current liabilities of CRSP is $119.45M
What is the all time high quarterly current liabilities for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high quarterly total current liabilities is $150.87M
What is CRISPR Therapeutics AG quarterly current liabilities year-on-year change?
Over the past year, CRSP quarterly total current liabilities has changed by +$457.00K (+0.38%)